EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

NF2 Inhibits CMPK2-Driven NLRP3 Inflammasome Activation to Alleviate Podocyte Injury in FSGS

Li Yang, Qinqin Tan, Hui Yin iD, Lan Qiu iD, Xindi Zhou, Huimin Jiang, Qing Yang, Han Xiao, Wei Jiang, Xuejun Yang iD, Qiu Li iD

Journal of Inflammation Research · 2026-10 · Volume 19 · 1-19

DOI: 10.2147/jir.s615100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inflammation Research, 2026-10. Verfasst von Li Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims: Therapeutic strategies directly targeting podocyte injury in focal segmental glomerulosclerosis (FSGS) are limited. Although NF2 is known to regulate cytoskeletal dynamics and cellular homeostasis, its role in podocyte inflammatory injury and downstream mechanisms remains unclear. This study investigated the function of NF2 and its regulatory relationship with CMPK2 in FSGS.

Methods

NF2 expression was assessed in kidney tissues from FSGS patients and experimental models. In vivo and in vitro models were used to evaluate the effects of NF2 modulation on podocyte function. Gain- and loss-of-function approaches examined NF2-CMPK2 interactions and downstream inflammatory signaling pathways.

Results

NF2 was predominantly expressed in podocytes and significantly downregulated in kidney tissues from FSGS patients and experimental models. NF2 knockdown in human podocytes upregulated CMPK2, activating the NLRP3 inflammasome and promoting IL-1β release, leading to enhanced inflammatory injury. Conversely, NF2 overexpression suppressed CMPK2, inhibited NLRP3 inflammasome activation, reduced IL-1β production, and alleviated podocyte injury.

Conclusion

Our findings indicate that NF2 confers protection against podocyte inflammatory injury, likely via modulation of the CMPK2-NLRP3 inflammasome signaling, pointing to a potential therapeutic target for FSGS.

Schlagwörter

Stichwörter der Autor:innen

CMPK2FSGSNF2NLRP3 inflammasomepodocyte

Autor:innen und Institutionen

  • Department of Nephrology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health and Diseases, Ministry of Education Key Laboratory of Child Developme…

ORCID-Profile: Hui Yin, Lan Qiu, Xuejun Yang, Qiu Li

Zitieren

APA

Yang, L., Tan, Q., Yin, H., Qiu, L., Zhou, X., Jiang, H., Yang, Q., Xiao, H., Jiang, W., Yang, X., & Li, Q. (2026). NF2 Inhibits CMPK2-Driven NLRP3 Inflammasome Activation to Alleviate Podocyte Injury in FSGS. Journal of Inflammation Research, Volume 19, 1-19. https://doi.org/10.2147/jir.s615100

Vancouver

Yang L, Tan Q, Yin H, Qiu L, Zhou X, Jiang H, et al. NF2 Inhibits CMPK2-Driven NLRP3 Inflammasome Activation to Alleviate Podocyte Injury in FSGS. Journal of Inflammation Research. 2026;Volume 19:1-19. doi:10.2147/jir.s615100

BibTeX
@article{Yang2026,
  author = {Yang, Li and Tan, Qinqin and Yin, Hui and Qiu, Lan and Zhou, Xindi and Jiang, Huimin and Yang, Qing and Xiao, Han and Jiang, Wei and Yang, Xuejun and Li, Qiu},
  title = {NF2 Inhibits CMPK2-Driven NLRP3 Inflammasome Activation to Alleviate Podocyte Injury in FSGS},
  journal = {Journal of Inflammation Research},
  year = {2026},
  volume = {Volume 19},
  pages = {1--19},
  doi = {10.2147/jir.s615100}
}
Kostenlos starten →